Galaxy Gaming Announces Second Quarter 2015 Financial Results Teleconference and Webcast

20:00 EDT 10 Aug 2015 | Globe Newswire

LAS VEGAS, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Galaxy Gaming, Inc. (OTC:GLXZ), announced today it will host an investor teleconference and webcast to discuss the Company's financial results for the six months ended June 30, 2015. The Las Vegas based company is the world's largest independent developer, manufacturer and distributor of cutting edge products for the casino industry, including casino table games, enhanced game systems, e-Tables and other ancillary products. Details for the call, which is scheduled to include a web presentation, are as follows:

Conference Call

When: Tuesday, August 18th at 1:00pm Pacific Time (4:00pm Eastern)
US/Canada: (888) 572-7033
International: (719) 325-2455
Passcode: 6598538
Web Presentation:

The Company is expected to file its annual report Form 10-K with the U.S. Securities and Exchange Commission on or before Friday, August 14, 2015.

About Galaxy Gaming

Headquartered in Las Vegas, Galaxy Gaming ( develops, manufactures and distributes innovative proprietary table games, state-of-the-art electronic wagering platforms and enhanced bonusing systems to land-based, riverboat, cruise ships and online casinos worldwide. Through its iGaming partner, Games Marketing, Ltd., Galaxy Gaming licenses its proprietary table games to the online gaming industry. The Company is also expanding its global presence through its partnership with WPT Enterprises, Inc., owner of the World Poker Tour. Galaxy Gaming is also the exclusive provider of SpectrumVision, a proprietary technology used to detect invisible markings on playing cards. Galaxy's games can be played online at Connect with Galaxy on Facebook, YouTube and Twitter.

CONTACT: Galaxy Gaming
         Gary A. Vecchiarelli
         (702) 939-3254

company logo


More From BioPortfolio on "Galaxy Gaming Announces Second Quarter 2015 Financial Results Teleconference and Webcast"

Quick Search


Relevant Topics

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...